Multiplex PCR (Polymerase Chain Reaction) quantitative detection method for high-pathogenicity bacteria in environmental water body
By designing primer and probe compositions for 12 pathogenic bacteria in water, combined with multiple real-time fluorescence quantitative PCR methods, the problems of complicated and insufficient sensitivity of detection of pathogenic microorganisms in water bodies in the prior art are solved, and rapid and efficient , quantitative testing meets the needs of drinking water monitoring.
Patent Information
- Application Number
- CN202411452597.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-17
- Publication Date
- 2024-12-06
AI Technical Summary
The prior art when detecting pathogenic microorganisms in water bodies, the methods are cumbersome and time-consuming, and the sensitivity and specificity are insufficient, making it difficult to meet the needs of fast, efficient and quantitative detection, especially when the concentration of pathogenic bacteria is low or unculturable.
A composition was designed, including 12 pairs of primer pairs and 12 probes, for the detection of 12 pathogenic bacteria simultaneously, and by multi-real-time fluorescence quantitative PCR method, combining fluorophores and quenching group markers, achieving multi-dimensional Fast, efficient and quantitative detection of pathogenic bacteria.
The simultaneous detection of 12 pathogenic bacteria in the water body is achieved, which reduces the detection cost, improves the detection efficiency, has high sensitivity and specificity, and can meet the needs of drinking water monitoring.
Smart Images

Figure BDA0005089581950000081 
Figure BDA0005089581950000091 
Figure BDA0005089581950000092
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology, and in particular relates to a multiplex PCR quantitative detection method for highly pathogenic bacteria in environmental water. Background Art
[0002] Water is an indispensable natural resource for human life. There are many kinds of microorganisms in water. So far, more than 1,400 kinds of pathogenic microorganisms have been found in water, including bacteria, viruses, protozoa, etc. Waterborne diseases are one of the main health threats facing the world today and can cause catastrophic consequences. Therefore, we should pay great attention to the pollution of pathogenic microorganisms in water. It is particularly important to quickly, efficiently and accurately determine the types and quantities of pathogenic microorganisms in water.
[0003] Traditional methods for detecting bacteria in drinking water require multiple complex steps, including culturing and enriching bacteria in different culture media, isolating and culturing, and verifying multiple physical and chemical properties. These processes are not only cumbersome and time-consuming, but also very difficult to cultivate when the bacterial concentration is low or in a non-culturable state (VBNC). This leads to a long overall detection cycle and large deviations in the test results, affecting the speed, sensitivity and specificity of the detection, and it is also difficult to meet the current needs for batch sample testing. With the rapid development of molecular biotechnology, a variety of new methods have emerged in recent years, including polymerase chain reaction (PCR), multiplex PCR, loop-mediated constant temperature amplification technology (LAMP), fluorescent quantitative PCR and gene chips. However, these methods also have certain limitations. Ordinary PCR can achieve rapid detection of pathogenic bacteria, but its sensitivity is low and quantitative analysis cannot be performed. In contrast, multiplex PCR allows the detection of multiple target bacteria in the same system, but because different primers are prone to mutual interference, the design and quality requirements of the primers are high, which increases the complexity of the experiment. Although LAMP technology has the advantages of small reaction system, high sensitivity and good specificity, non-specific bands may be generated during the amplification process, resulting in false positive results. Although multiplex PCR, LAMP and gene chip methods have the ability to detect multiple pathogens at the same time, they cannot achieve quantitative detection of pathogens. Although fluorescent quantitative PCR can perform quantitative analysis, due to the limitations of primer and probe design, one experiment can usually only detect one pathogen. These problems have prompted researchers to seek more effective solutions.
[0004] In view of this, exploring and developing faster, more efficient and more accurate quantitative detection methods for multiple target pathogens is crucial to better meet the actual needs of drinking water safety monitoring, and has broad application potential in the field of water pathogenic microorganism detection. Summary of the invention
[0005] The technical problem to be solved by the present invention is how to detect twelve pathogenic bacteria in water quickly, sensitively, specifically and efficiently. The technical problem to be solved is not limited to the technical subject described, and those skilled in the art can clearly understand other technical subjects not mentioned in this article through the following description.
[0006] In order to solve the above technical problems, the present invention first provides a composition for simultaneously detecting multiple microorganisms, wherein the composition comprises 12 pairs of primers, and the nucleotide sequences of the 12 pairs of primers can be shown as SEQ ID No.1-SEQ ID No.24.
[0007] The plurality of microorganisms may be the following 12 microorganisms: Acinetobacterbaumannii, Aeromonas hydrophila, Campylobacterjejuni, Clostridiumperfringens, Enterotoxigenic Escherichia coli (ETEC), Enterobacter sakazakii, Enterococcus faecalis, Klebsiellaoxytoca, Mycobacteriumkansasii, Salmonellabongori, Shigelladysenteriae and Vibriovulnificus.
[0008] Furthermore, the composition may also include 12 probes, and the nucleotide sequences of the 12 probes may be shown as SEQ ID No.25-SEQ ID No.36.
[0009] The 12 pairs of primers and the 12 probes are used to detect the 12 microorganisms.
[0010] The primer pair for detecting Acinetobacter baumannii is composed of two single-stranded DNA molecules shown in SEQ ID No. 1 and SEQ ID No. 2; the nucleotide sequence of the probe for detecting Acinetobacter baumannii is shown in SEQ ID No. 25;
[0011] The primer pair for detecting Aeromonas hydrophila is composed of two single-stranded DNA molecules shown in SEQ ID No. 3 and SEQ ID No. 4; the nucleotide sequence of the probe for detecting Aeromonas hydrophila is shown in SEQ ID No. 26;
[0012] The primer pair for detecting Campylobacter jejuni is composed of two single-stranded DNA molecules shown in SEQ ID No. 5 and SEQ ID No. 6; the nucleotide sequence of the probe for detecting Campylobacter jejuni is shown in SEQ ID No. 27;
[0013] The primer pair for detecting Clostridium perfringens is composed of two single-stranded DNA molecules shown in SEQ ID No. 7 and SEQ ID No. 8; the nucleotide sequence of the probe for detecting Clostridium perfringens is shown in SEQ ID No. 28;
[0014] The primer pair for detecting enterotoxigenic Escherichia coli is composed of two single-stranded DNA molecules shown in SEQ ID No. 9 and SEQ ID No. 10; the nucleotide sequence of the probe for detecting enterotoxigenic Escherichia coli is shown in SEQ ID No. 29;
[0015] The primer pair for detecting Enterobacter sakazakii is composed of two single-stranded DNA molecules shown in SEQ ID No. 11 and SEQ ID No. 12; the nucleotide sequence of the probe for detecting Enterobacter sakazakii is shown in SEQ ID No. 30;
[0016] The primer pair for detecting Enterococcus faecalis is composed of two single-stranded DNA molecules shown in SEQ ID No. 13 and SEQ ID No. 14; the nucleotide sequence of the probe for detecting Enterococcus faecalis is shown in SEQ ID No. 31;
[0017] The primer pair for detecting Klebsiella oxytoca is composed of two single-stranded DNA molecules shown in SEQ ID No. 15 and SEQ ID No. 16; the nucleotide sequence of the probe for detecting Klebsiella oxytoca is shown in SEQ ID No. 32;
[0018] The primer pair for detecting Mycobacterium kansasii is composed of two single-stranded DNA molecules shown in SEQ ID No. 17 and SEQ ID No. 18; the nucleotide sequence of the probe for detecting Mycobacterium kansasii is shown in SEQ ID No. 33;
[0019] The primer pair for detecting Salmonella bongori is composed of two single-stranded DNA molecules shown in SEQ ID No. 19 and SEQ ID No. 20; the nucleotide sequence of the probe for detecting Salmonella bongori is shown in SEQ ID No. 34;
[0020] The primer pair for detecting Shigella dysenteriae is composed of two single-stranded DNA molecules shown in SEQ ID No.21 and SEQ ID No.22; the nucleotide sequence of the probe for detecting Shigella dysenteriae is shown in SEQ ID No.35;
[0021] The primer pair for detecting Vibrio vulnificus consists of two single-stranded DNA molecules shown in SEQ ID No.23 and SEQ ID No.24; the nucleotide sequence of the probe for detecting Vibrio vulnificus is shown in SEQ ID No.36.
[0022] In the above composition, the 5' end of the probe may be labeled with a fluorescent group, and the 3' end may be labeled with a quenching group.
[0023] Furthermore, the fluorescent group can be selected from FAM, VIC, HEX, TET, CY3, CY5, ROX, JOE, FITC, TET, NED, TAMRA, LC RED640, LC RED705, Quasar705 and Texas Red.
[0024] Further, the quenching group can be selected from TAMRA, BHQ1, BHQ2, BHQ3, MGB and Dabcy1.
[0025] The fluorescent groups of each probe in the composition can be different. For example, when the detection is based on the kit, different probes can be labeled with different fluorescent groups to facilitate the distinction and quantitative analysis of multiple target sequences. The same fluorescent group can also be labeled. For example, when the detection is based on a DNA chip, different target sequences can be distinguished by spatial position encoding. In this case, the probes can use the same fluorescent group to accurately identify each target based on the physical layout on the chip.
[0026] The present invention also provides a kit for simultaneously detecting multiple microorganisms, wherein the kit comprises any one of the compositions described herein.
[0027] Furthermore, the kit may also include reagents required for fluorescence quantitative PCR detection.
[0028] Furthermore, the kit may also include a nucleic acid extraction reagent, a DNA polymerase, dNTPs, Mg 2+ One or more of solution (such as MgSO4 or MgCl2 solution), PCR buffer (such as Tris-HCl), positive control, negative control, and standard.
[0029] The nucleic acid extraction reagent is well known to those skilled in the art and is used to extract nucleic acids from the sample to be tested. For example, the nucleic acid extraction reagent may include a lysing solution (such as any one or more of guanidine isothiocyanate, guanidine hydrochloride and trisodium citrate), lysozyme, proteinase K, a washing solution (such as ethanol and / or guanidine salt) and / or an eluent (such as TE buffer), etc.
[0030] The positive control substance may be the same as the standard substance, and may be the following (1) or (2):
[0031] (1) 12 genes or their fragments: AbaR gene or its fragment of Acinetobacter baumannii, aerA gene or its fragment of Aeromonas hydrophila, hipO gene or its fragment of Campylobacter jejuni, plc gene or its fragment of Clostridium perfringens, estA gene or its fragment of enterotoxigenic Escherichia coli, ompA gene or its fragment of Enterobacter sakazakii, gelE gene or its fragment of Enterococcus faecalis, pehX gene or its fragment of Klebsiella oxytoca, HSP65 gene or its fragment of Mycobacterium kansasii, stn gene or its fragment of Salmonella bongori, ipah gene or its fragment of Shigella dysenteriae, and RtxA gene or its fragment of Vibrio vulnificus.
[0032] For example, the 12 gene fragments may be: a gene fragment amplified from SEQ ID No. 1 and SEQ ID No. 2 using Acinetobacter baumannii as a template, a gene fragment amplified from SEQ ID No. 3 and SEQ ID No. 4 using Aeromonas hydrophila as a template, a gene fragment amplified from SEQ ID No. 5 and SEQ ID No. 6 using Campylobacter jejuni as a template, a gene fragment amplified from SEQ ID No. 7 and SEQ ID No. 8 using Clostridium perfringens as a template, a gene fragment amplified from SEQ ID No. 9 and SEQ ID No. 10 using enterotoxigenic Escherichia coli as a template, a gene fragment amplified from SEQ ID No. 11 and SEQ ID No. 12 using Enterobacter sakazakii as a template, a gene fragment amplified from SEQ ID No. 13 and SEQ ID No. 14 using Enterococcus faecalis as a template, a gene fragment amplified from SEQ ID No. 15 and SEQ ID No. 16 using Klebsiella oxytoca as a template, a gene fragment amplified from SEQ ID No. 17 and SEQ ID No. 18 using Mycobacterium kansasii as a template, The gene fragment amplified from SEQ ID No.18 using Salmonella bongori as a template, the gene fragment amplified from SEQ ID No.19 and SEQ ID No.20 using Shigella dysenteriae as a template, and the gene fragment amplified from SEQ ID No.23 and SEQ ID No.24 using Vibrio vulnificus as a template.
[0033] (2) Positive plasmid: a recombinant vector containing the 12 genes or their fragments described in (1).
[0034] The negative control substance can be selected from ultrapure water (ddH2O), distilled water, deionized water, water for injection and redistilled water.
[0035] Furthermore, the detection sample of the kit may be an environmental sample (such as water, soil, air, etc.).
[0036] The various reagent components of the kit may be present in separate containers, or may be pre-combined in whole or in part into a reagent mixture.
[0037] The components of the kit may be provided in the form of a solution, such as an aqueous solution. In the case of being in the form of an aqueous solution, the concentration or content of these components can be easily determined by those skilled in the art according to different needs. For example, for storage purposes, the concentration of the components may be present in a higher form, and when in working state or use, the concentration may be reduced to the working concentration by diluting the above-mentioned higher concentration solution.
[0038] Further, the kit may also include a readable carrier having a method for simultaneously detecting multiple microorganisms as described herein. The readable carrier may be a kit instruction sheet (e.g., a printed instruction sheet) for practicing the method of the present invention or a computer-readable medium (e.g., a floppy disk, a CD, etc.) on which information has been recorded.
[0039] The kit described herein may be a detection kit based on real-time fluorescence quantitative PCR.
[0040] The present invention also provides a DNA chip for simultaneously detecting multiple microorganisms, wherein the DNA chip may include any of the compositions described herein.
[0041] The carrier used for the DNA chip described herein may include glass chips, silicon chips, membrane chips (such as nitrocellulose membranes and nylon membranes) and ceramic chips.
[0042] The DNA chip described herein can be prepared by methods known to those skilled in the art, such as by in situ synthesis of oligonucleotide probe chips (including in situ light-guided synthesis technology, in situ inkjet synthesis technology and molecular stamp multiple imprint synthesis method) or by pre-synthesizing probe spotting chips. Specifically, the primers and probes (SEQ ID No. 1-SEQ ID No. 36) of the present invention can be spotted on a chip carrier using a fully automatic spotting instrument. After the spotting is completed, the DNA chip is placed in a desiccator in the dark and allowed to stand at room temperature, so that the primers, probes and chip are covalently bonded to form a DNA chip.
[0043] The present invention also provides the use of any of the compositions, kits or DNA chips described herein in detecting 12 microorganisms in environmental samples, wherein the 12 microorganisms are Acinetobacter baumannii, Aeromonas hydrophila, Campylobacter jejuni, Clostridium perfringens, enterotoxigenic Escherichia coli, Enterobacter sakazakii, Enterococcus faecalis, Klebsiella oxytoca, Mycobacterium kansasii, Salmonella bongori, Shigella dysenteriae and / or Vibrio vulnificus.
[0044] The present invention also provides use of any of the compositions described herein in the preparation of a product for detecting the 12 microorganisms.
[0045] The products described herein are selected from reagents, test kits, chips, test strips and test cards.
[0046] The present invention also provides a method for simultaneously detecting multiple microorganisms, which may include the following steps:
[0047] A1) extracting DNA from the sample to be tested;
[0048] A2) using the DNA as a template, performing multiplex real-time fluorescence quantitative PCR using any of the compositions, the kits or the DNA chips described herein, and determining whether the sample to be tested contains microorganisms based on the PCR results.
[0049] In the above method, the reaction procedure of the multiplex real-time fluorescence quantitative PCR can be: dissolution at 25°C for 2 minutes; dissolution at 50°C for 15 minutes; pre-denaturation at 95°C for 10 minutes; 40 cycles, each cycle including denaturation at 95°C for 3 seconds and annealing and extension at 60°C for 1 minute.
[0050] In the above method, in the reaction system of the multiplex real-time fluorescence quantitative PCR, the concentration of each primer can be 900 nM, and the concentration of the probe can be 250 nM.
[0051] Furthermore, judging the presence of microorganisms in the sample to be tested based on the PCR result may include any of the following methods:
[0052] (1) If the Ct value of a gene in the sample to be tested is less than or equal to 35, it is judged that the sample contains pathogenic bacteria with the gene. If the Ct value of a gene in the sample to be tested is greater than 35, it is judged that the sample does not contain pathogenic bacteria with the gene;
[0053] (2) If the amplification curve of a gene is an S-shaped curve, it is judged that the sample contains pathogenic bacteria possessing the gene. If the amplification curve of a gene is not an S-shaped curve, it is judged that the sample does not contain pathogenic bacteria possessing the gene.
[0054] Furthermore, the sample to be tested can be quantitatively analyzed, for example, a standard with a known content is diluted into samples of different concentrations, and real-time fluorescence quantitative PCR amplification is performed simultaneously with the sample to be tested, and a standard curve is drawn according to the detection data (the horizontal axis is the logarithm of the starting copy number of the standard, and the vertical axis is the Ct value). When the sample to be tested is quantitatively analyzed, the starting copy number of the sample to be tested can be calculated from the standard curve equation according to the Ct value of the sample to be tested.
[0055] The sample to be tested described herein may be an environmental sample, such as water, soil, air, etc.
[0056] The method of the present invention can be used for non-disease diagnosis purposes, non-disease prognosis purposes, and non-disease treatment purposes.
[0057] The multiplex PCR is a method of using multiple pairs of primers to simultaneously amplify several different DNA fragments. The design of multiplex PCR is much more complicated than single PCR. It is not simply a combination of multiple pairs of specific primers. The composition and reaction conditions of the reaction system need to be repeatedly adjusted and explored to meet the needs of amplifying multiple fragments at the same time.
[0058] The present invention establishes a multiplex real-time fluorescence quantitative PCR method by accurately designing primers and probes for specific pathogenic genes and optimizing reaction conditions. The method simultaneously amplifies specific gene fragments of pathogenic bacteria and obtains quantitative detection results through standard curve analysis. It can quantitatively and simultaneously detect 12 major pathogenic bacteria commonly found in water bodies (such as drinking water) (Acinetobacter baumannii, Aeromonas hydrophila, Campylobacter jejuni, Clostridium perfringens, enterotoxigenic Escherichia coli, Enterobacter sakazakii, Enterococcus faecalis, Klebsiella oxytoca, Mycobacterium kansasii, Salmonella bongori, Shigella dysenteriae and Vibrio vulnificus). Experiments have shown that the present invention has the following advantages over the prior art:
[0059] 1) The 12 pathogenic bacteria involved in the method of the present invention can simultaneously achieve specific gene fragment amplification in the same reaction system and reaction procedure, and the standard curve made fully meets the requirements of quantitative detection; the detection cost is reduced and the detection efficiency is greatly improved.
[0060] 2) The specific primers and probes for the 12 pathogenic bacteria used in the method of the present invention have been tested for specificity and sensitivity, and their detection levels are equivalent to those of commercial kits;
[0061] 3) The specific primers and probes for the 12 pathogenic bacteria used in the method of the present invention have not been reported in previous studies.
[0062] In summary, the composition of the present invention can be developed into a detection kit or DNA chip, which can quickly detect multiple samples with high coverage, high throughput and low cost, and has the characteristics of high sensitivity and good specificity. The detection method of the present invention not only improves the detection efficiency, but also solves the problem of quantitative detection, has a wide range of application potential, and can better meet the needs of drinking water monitoring.
[0063] Definition of terms
[0064] In the present invention, unless otherwise specified, the scientific and technical terms used herein have the meanings commonly understood by those skilled in the art. Meanwhile, in order to better understand the present invention, the definitions and explanations of the relevant terms are provided below.
[0065] The term "fluorescent group" generally refers to the chromophore in a fluorescent compound, ie, a group that can produce fluorescence.
[0066] The term "quencher" generally refers to a chemical substance used to eliminate a fluorescent signal. When a fluorescent group is close to a quencher, the quencher absorbs the fluorescence emitted by the fluorescent group, causing the fluorescent signal to weaken or disappear.
[0067] The term "amplification curve" generally refers to the amplification curve obtained by fluorescence quantitative PCR. As the PCR reaction proceeds, the amplification product accumulates and the intensity of the fluorescence signal increases. After each cycle, the fluorescence signal is collected and the change in the amount of the amplification product is monitored by the change in fluorescence intensity. Usually, the ordinate of the amplification curve is the fluorescence value and the abscissa is the number of cycles.
[0068] The term "Ct value" generally refers to the number of PCR cycles corresponding to the fluorescence value when the fluorescence signal of the amplified product reaches the set threshold during the PCR amplification process. It can also be understood as the horizontal coordinate corresponding to the intersection of the amplification curve and the threshold line. Generally, when the same template is amplified in the same cycle, the Ct value is relatively fixed.
[0069] The term "positive control (also called amplification positive control)" usually refers to a set of controls that can be detected for sure, such as target genes (such as genomic DNA or cDNA), target gene fragments (such as specific conserved fragments), plasmids containing target genes or target gene fragments, pseudoviruses, etc., and positive sample controls (such as known infected samples or samples known to definitely produce expected results). The role of positive controls is to prevent false negatives in PCR detection due to problems such as loss or degradation of target DNA, inactivation of DNA polymerase, and PCR instrument failure.
[0070] The term "negative control (also called amplification negative control)" usually refers to a set of controls that will definitely not be detected, such as a no-template control (NTC, water is used instead of nucleic acid in the PCR reaction, and other reagents are added in normal proportions), or a negative sample control (such as a sample that does not express the target gene). The role of negative controls is to prevent false positives in PCR detection due to product contamination, reagent contamination, cross-contamination between samples, sample collection and transportation contamination, etc.
[0071] The term "DNA chip", also known as gene chip, usually refers to oligonucleotides or DNA fragments that are regularly and densely fixed and arranged on a support (such as a glass slide, silicon wafer or fiber membrane, etc.) to form spots. The spots are then hybridized with the DNA sample to be tested according to the base pairing principle. The chip is then scanned by a detection system, and the signals of each spot are detected and compared with the help of a computer, thereby performing high-throughput, large-scale analysis and research on the measured sequences and functions.
[0072] The term "multiplex real-time fluorescence quantitative PCR" usually refers to the fusion of multiplex PCR and real-time fluorescence quantitative PCR. By amplifying multiple DNA fragments in the same reaction system, multiple target genes can be detected simultaneously. Specific probes are designed for each target gene, and real-time quantitative detection of multiple targets is achieved by using fluorescent groups labeled on different probes and combining the instrument's ability to detect fluorescence in different channels. In a multiplex real-time fluorescence quantitative PCR reaction, multiple templates are amplified in parallel under the same conditions, and each amplicon provides an internal control for other amplicons, making it easier to identify false negative problems caused by potential PCR reaction failures. BRIEF DESCRIPTION OF THE DRAWINGS
[0073] Figure 1 This is the primer probe amplification performance verification result in Example 3.
[0074] Figure 2 This is the primer-probe specificity verification result in Example 4.
[0075] Figure 3 This is the standard curve of the 12 pathogenic bacteria in Example 5.
[0076] Figure 4 The results are compared between the multiplex PCR in Example 6 and the detection results of the commercial kit. DETAILED DESCRIPTION
[0077] The present invention is further described in detail below in conjunction with specific embodiments, and the examples provided are only for illustrating the present invention, rather than for limiting the scope of the present invention. The examples provided below can be used as a guide for further improvements by those of ordinary skill in the art, and do not constitute a limitation of the present invention in any way.
[0078] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.
[0079] The 12 pathogenic bacteria (Acinetobacter baumannii, Aeromonas hydrophila, Campylobacter jejuni, Clostridium perfringens, enterotoxigenic Escherichia coli, Enterobacter sakazakii, Enterococcus faecalis, Klebsiella oxytoca, Mycobacterium kansasii, Salmonella bongori, Shigella dysenteriae and Vibrio vulnificus) in the following examples were purchased from Beijing Beina Chuanglian Biotechnology Research Institute.
[0080] Example 1: Selection of target genes and design of primers and probes
[0081] According to China's current GB5749-2022 "Sanitary Standards for Drinking Water", the Catalogue of Pathogenic Microorganisms Transmitted by Humans (2023 Edition), the World Health Organization (WHO) "Guidelines for Drinking-water Quality: Fourth Edition Incorporating the First Addendum" and the relevant regulations of the United States Environmental Protection Agency (USEPA) on drinking water and recreational water, the main pathogenic microorganisms present in water bodies are identified as: Acinetobacter baumannii, Aeromonas hydrophila, Campylobacter jejuni, Clostridium perfringens, Enterotoxigenic Escherichia coli (ETEC), Enterobacter sakazakii, Enterococcus faecalis, Klebsiella oxytoca, Mycobacterium kansasii, Salmonella bongori, Shigella dysenteriae and Vibrio vulnificus.
[0082] For the above 12 target pathogens, virulence genes located on the bacterial genome were selected as target genes. Although the genome homology between various pathogenic bacteria is very high, and there is no difference in biochemical reactions with the non-pathogenic types of the same genus, the virulence genes related to pathogenicity are highly specific, so virulence genes are selected as target genes with strong specificity. The target genes selected are Acinetobacter baumannii (AbaR gene), Aeromonas hydrophila (aerA gene), Campylobacter jejuni (hipO gene), Clostridium perfringens (plc gene), enterotoxigenic Escherichia coli (estA gene), Enterobacter sakazakii (ompA gene), Enterococcus faecalis (gelE gene), Klebsiella oxytoca (pehX gene), Mycobacterium kansasii (HSP65 gene), Salmonella bongori (st n gene), Shigella dysenteriae (ipah gene) and Vibrio vulnificus (RtxA gene).
[0083] The whole genome sequence was retrieved from the database of the National Center for Biotechnology Information (NCBI) (http: / / www.ncbi.nlm.nih.gov / ). Primers and probes were designed using the Primer Express software for real-time PCR 3.0. The basic principles for primer and probe design are as follows: (1) give priority to the probe position; (2) the first base at the 5' end of the probe cannot be G; (3) the probe length is 13-30 bp; (4) probes with more C bases than G bases are more effective; (5) avoid too many repetitions of the same base, especially 4 or more consecutive Gs; (6) the primer is as close to the probe as possible, but cannot overlap with the probe; (7) the primer length is 9-40 bp, with 20 bp being optimal, and the GC content is between 30% and 80%; (8) avoid forming 4 or more consecutive pairs between the primer itself or with other primers; (9) avoid the primer itself forming a circular hairpin structure; (10) the length of the amplified fragment is between 50 bp and 150 bp. After the design was completed, Primer-BLAST analysis was performed on NCBI to verify the specificity of the designed primers and probes. Both primers and probes were commissioned to be synthesized by Shanghai Bioengineering Co., Ltd. (Table 1).
[0084] Table 1. Primer and probe nucleotide sequences of 12 pathogenic microorganisms
[0085]
[0086] The 5' end of each probe in Table 1 is labeled with FAM, and the 3' end is labeled with NQF.
[0087] Example 2: Establishment of a multiplex real-time fluorescence quantitative PCR method for simultaneous detection of 12 pathogenic bacteria
[0088] 1. Water sample treatment
[0089] Take 10L of water sample and filter it through a 142mm diameter 0.20μm pore size microporous membrane with a pressure ≤0.2MPa.
[0090] 2. Extract DNA from samples to be tested
[0091] Cut the filter membrane into pieces and place them in two 5 ml grinding tubes, add grinding beads (1 6 mm + 8 3 mm beads), add 1200 μL lysis solution and 3 μL Carrier RNA, vortex to mix, break up the solid sample thoroughly, resuspend it in the solution, and homogenize it with a tissue grinder homogenizer. The homogenization program is to oscillate at a speed of 6 m / s for 20 seconds, with an interval of 20 seconds, for a total of 6 cycles; then use a magnetic bead method environmental microbial genomic DNA extraction kit (Tian Gen, DP712-T5) for DNA extraction.
[0092] 3. Multiplex real-time fluorescence quantitative PCR detection
[0093] ThermoFisher SCIENTIFIC was commissioned to embed primers and probes into the chip. Each detection well includes the primers and probes of the pathogen to be detected. The sample DNA and TaqPath TM BactoPure TM Microbial Detection Master Mix (purchased from ThermoFisher SCIENTIFIC, catalog number: A15297) was added to the chip from the sample loading channel for multiplex PCR amplification. The negative control was ultrapure water (ddH2O). The PCR reaction system was shown in Table 2, and the PCR reaction procedure was shown in Table 3.
[0094] Table 2. Multiplex real-time fluorescence quantitative PCR reaction system
[0095]
[0096] Table 3. Multiplex real-time fluorescence quantitative PCR reaction program
[0097]
[0098] 4. Interpretation of results
[0099] (1) If the Ct value of a gene in the sample to be tested is less than or equal to 35, it is judged that the sample contains pathogenic bacteria with the gene. If the Ct value of a gene in the sample to be tested is greater than 35, it is judged that the sample does not contain pathogenic bacteria with the gene.
[0100] (2) If the amplification curve of a gene is an S-shaped curve, it is judged that the sample contains pathogenic bacteria possessing the gene. If the amplification curve of a gene is not an S-shaped curve, it is judged that the sample does not contain pathogenic bacteria possessing the gene.
[0101] Quantification: Dilute the known content of the standard into samples of different concentrations, perform real-time fluorescence quantitative PCR amplification with the sample to be tested, and draw a standard curve based on the test data (the horizontal axis is the logarithm of the starting copy number of the standard, and the vertical axis is the Ct value). When quantifying the sample to be tested, the starting copy number of the sample to be tested can be calculated from the standard curve equation based on the Ct value of the sample to be tested.
[0102] Example 3: Verification of primer-probe amplification performance of 12 pathogenic bacteria
[0103] After culturing 12 pathogenic bacteria according to their respective culture conditions, 8 ~10 9 The nucleic acid DNA of each CFU / mL bacterial solution was extracted according to QIAGEN's QIAamp DNA Microbiome Kit. The extracted DNA was used as a template, and the corresponding components were added according to the amplification system in Table 2. The fluorescence quantitative PCR reaction was performed on the Q7 quantitative PCR instrument according to the reaction program in Table 3. Two parallel samples and one negative control were tested for each pathogen. The amplification curve is shown in Figure 1 .from Figure 1 As can be seen from the results, the amplification curves of the 12 designed and synthesized Taqman probe primers for quantification of pathogenic genes were good. Figure 1 , indicating that the primer-probe reaction performance is good and can be used in fluorescence quantitative PCR experiments.
[0104] Example 4: Primer-probe specificity verification
[0105] In order to verify the specificity of the primer probes of the 12 pathogens, the DNA of 11 pathogens was used to test the primer probe specific to another pathogen. The corresponding components were added according to the amplification system in Table 2, and the fluorescence quantitative PCR reaction was performed on the Q7 quantitative PCR instrument according to the reaction program in Table 3. A positive sample was tested for each pathogen DNA verification, and the results are shown in Figure 2 There was no cross-reaction among the 12 pathogen-specific primers and probes.
[0106] Example 5: Establishment of standard curve and verification of primer-probe sensitivity
[0107] DNA of 12 pathogenic bacteria (Acinetobacter baumannii, Aeromonas hydrophila, Campylobacter jejuni, Clostridium perfringens, enterotoxigenic Escherichia coli, Enterobacter sakazakii, Enterococcus faecalis, Klebsiella oxytoca, Mycobacterium kansasii, Salmonella bongori, Shigella dysenteriae, and Vibrio vulnificus) were extracted and analyzed using Naica TMCrystalDigital PCR System microdroplet chip digital PCR was used to quantify the nucleic acid DNA of 12 pathogens. The nucleic acid DNA of pathogens was gradiently diluted to 10 using DNA Dilution Buffer of Shanghai Bioengineering Co., Ltd. 5 , 10 4 , 10 3 , 10 2 , 10 1 , 10 0 1000 copies / μL, vortex and centrifuge. Use the gradient diluted DNA standard as template, add the corresponding components according to the amplification system in Table 2, and perform fluorescence quantitative PCR reaction on the Q7 quantitative PCR instrument according to the program in Table 3. After the reaction is completed, the Ct value and log are prepared according to the amplification curve. 10 (DNA concentration) standard curve. The results are as follows Figure 3 As shown in Table 4, the standard curve showed a good linear relationship (R 2 >0.99), the amplification efficiency met the standard curve requirements (90% < E < 110%), and the constructed standard curve could be used to quantitatively analyze the copy numbers of 12 pathogenic bacteria in actual samples.
[0108] Table 4. Standard curves of 12 pathogenic bacteria
[0109] Pathogenic microorganisms Standard curve <![CDATA[R 2 ]]> E(%) Acinetobacter baumannii y=-3.5743x+43.350 0.9997 90.45 Aeromonas hydrophila y=-3.4865x+43.686 0.9956 93.56 Campylobacter jejuni y=-3.4281x+40.370 0.9981 95.75 Clostridium perfringens y=-3.4064x+43.016 0.9926 96.59 Enterotoxigenic Escherichia coli y=-3.7849x+41.858 0.9978 92.5 Enterobacter sakazakii y=-3.2576x+41.710 0.995 102.76 Enterococcus faecalis y=-3.5696x+39.737 0.9847 90.61 Klebsiella oxytoca y=-3.4294x+41.026 0.9912 95.7 Mycobacterium kansasii y=-3.5243x+40.261 0.995 92.2 Salmonella Bango y=-3.4226x+38.670 0.9955 95.96 Shigella dysenteriae y=-3.4174x+34.382 0.999 96.16 Vibrio vulnificus y=-3.5306x+42.223 0.9952 91.97
[0110] The lowest concentration of the template diluted according to the standard curve can be used to determine the detection sensitivity. Figure 3 and Table 5. The results show that the multiplex real-time fluorescence PCR detection method of the present invention has high sensitivity.
[0111] Table 5. Detection sensitivity of 12 pathogenic bacteria
[0112] Pathogens Detection sensitivity (copies / μL) Acinetobacter baumannii 1 Aeromonas hydrophila 0.1 Campylobacter jejuni 1 Clostridium perfringens 1 Enterotoxigenic Escherichia coli 1 Enterobacter sakazakii 1 Enterococcus faecalis 1 Klebsiella oxytoca 0.1 Mycobacterium kansasii 1 Salmonella Bango 1 Shigella dysenteriae 10 Vibrio vulnificus 0.1
[0113] Example 6: Detection of real water samples
[0114] A total of 17 water samples were collected from Beijing's moat and the Yangtze River and Yellow River basins. According to the method established in Example 2, TaqPath TM BactoPure TM Microbial Detection Master Mix was used for amplification. The amplification system and components are shown in Table 2. The fluorescence quantitative PCR reaction was carried out on a Q7 quantitative PCR instrument. The program is shown in Table 3. At the same time, 12 pathogenic bacteria detection kits (as shown in Table 6) were selected for quantitative detection. The test results are shown in Tables 7 and 8.
[0115] Table 6. Detection kits for 12 pathogenic bacteria
[0116]
[0117] Table 7. Summary of quantitative detection results of 12 pathogenic bacteria in environmental water (copies / L)
[0118]
[0119] Table 8. Summary of quantitative detection results of 12 pathogenic bacteria in environmental water (copies / L)
[0120]
[0121] The test results of the two methods were logarithmically plotted ( Figure 4 ), from which we can see that the fit of the two methods is R 2 =0.7599, indicating that there is a strong correlation between the two methods, which further verifies the effectiveness and reliability of this method for quantitative detection of 12 pathogenic bacteria in environmental water bodies.
[0122] The present invention has been described in detail above. For those skilled in the art, without departing from the purpose and scope of the present invention, and without the need to carry out unnecessary experimental conditions, the present invention can be implemented in a wide range under equivalent parameters, concentrations and conditions. Although the present invention provides specific embodiments, it should be understood that the present invention can be further improved. In a word, according to the principles of the present invention, the application is intended to include any changes, uses or improvements to the present invention, including departure from the disclosed scope in the application, and changes made with conventional techniques known in the art.
Claims
1. A composition for simultaneously detecting multiple microorganisms, characterized in that: The composition comprises 12 pairs of primers, and the nucleotide sequences of the 12 pairs of primers are shown as SEQ ID No.1-SEQ ID No.
24.
2. The composition according to claim 1, characterized in that The composition further comprises 12 probes, and the nucleotide sequences of the 12 probes are shown as SEQ ID No.25-SEQ ID No.
36.
3. The composition according to claim 2, characterized in that The 5' end of the probe is labeled with a fluorescent group, and the 3' end is labeled with a quenching group.
4. A kit for simultaneously detecting multiple microorganisms, characterized in that: The kit comprises the composition according to any one of claims 1 to 3.
5. A DNA chip for simultaneously detecting multiple microorganisms, characterized in that: The DNA chip comprises the composition according to any one of claims 1-3.
6. Use of the composition according to any one of claims 1 to 3, the kit according to claim 4 or the DNA chip according to claim 5 in detecting 12 microorganisms in environmental samples, wherein the 12 microorganisms are Acinetobacter baumannii, Aeromonas hydrophila, Campylobacter jejuni, Clostridium perfringens, enterotoxigenic Escherichia coli, Enterobacter sakazakii, Enterococcus faecalis, Klebsiella oxytoca, Mycobacterium kansasii, Salmonella bongori, Shigella dysenteriae and / or Vibrio vulnificus.
7. Use of the composition according to any one of claims 1 to 3 in the preparation of a product for detecting the 12 microorganisms according to claim 6.
8. A method for simultaneously detecting multiple microorganisms, characterized in that: The method comprises the following steps: A1) extracting DNA from the sample to be tested; A2) using the DNA as a template, performing multiplex real-time fluorescence quantitative PCR using the composition according to any one of claims 1 to 3, the kit according to claim 4, or the DNA chip according to claim 5, and judging whether the sample to be tested contains microorganisms according to the PCR results.
9. The method according to claim 8, characterized in that The reaction procedure of the multiplex real-time fluorescence quantitative PCR is: dissolving at 25°C for 2 minutes; dissolving at 50°C for 15 minutes; pre-denaturing at 95°C for 10 minutes; 40 cycles were performed, each cycle including denaturation at 95°C for 3 s and annealing and extension at 60°C for 1 min.
10. The method according to claim 8 or 9, characterized in that: In the reaction system of the multiplex real-time fluorescence quantitative PCR, the concentration of each primer is 900 nM, and the concentration of the probe is 250 nM.
